24
Participants
Start Date
January 31, 2007
Primary Completion Date
July 31, 2015
Study Completion Date
July 5, 2017
Islet transplantation
Antithymocyte Globulin
Participants will begin receiving ATG 2 days prior to the initial islet transplant and will continue to receive ATG until Day 2 post-transplant.
Daclizumab or Basiliximab
Daclizumab or Basiliximab will be used for subsequent transplants.
Etanercept
Etanercept will be given on the day of transplant and on Days 3, 7, and 10 post-transplant.
Allogenic human purified pancreatic islets
200 ml suspension of allogenic human purified islets
University of Pennsylvania, Philadelphia
Emory Universtiy, Atlanta
University of Miami, Miami
University of Wisconsin, Madison
University of Minnesota, Minneapolis
Northwestern University, Chicago
University of Illinois at Chicago, Chicago
University of California, San Francisco, San Francisco
Massachusetts General Hospital, Boston
University of Alberta, Edmonton
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
National Institute of Allergy and Infectious Diseases (NIAID)
NIH